ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 1846 • ACR Convergence 2023

    A Longitudinal Study: The Benefits of Non-Pharmacological Approaches to Improve Self-Reported Pain, Stiffness, and Fatigue in Individuals with Musculoskeletal Disorders

    Titilayo Adeniran, Bertilia Trieu, Claudia Zurlini, Bonnie McGrath, Linda Roberts, Pamela Sanchez-Villagomez, Vilma Briones, Robyn Wiesel, Sandra Goldsmith and Laura Robbins, Hospital for Special Surgery, New York, NY

    Background/Purpose: Musculoskeletal disorders are a leading cause of disability worldwide, with low back pain being one of the primary causes. The World Health Organization (WHO)…
  • Abstract Number: 057 • 2023 Pediatric Rheumatology Symposium

    A “High-Risk” Depression/Fatigue Profile May Be Associated with Stronger Response to a Psychological Treatment for Childhood-Onset Systemic Lupus Erythematosus (cSLE)

    Elizabeth Ross1, khalid abulaban2, Elizabeth Kessler2, Andrea Knight3 and Natoshia Cunningham4, 1Michigan State University College of Human Medicine, Grand Rapids, MI, 2Helen DeVos Children's Hospital, Grand Rapids, MI, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Michigan State University, Grand Rapids, MI

    Background/Purpose: Children with childhood-onset systemic lupus erythematosus (cSLE) experience more severe disease than their adult counterparts, in addition to high rates of clinical depressive symptoms…
  • Abstract Number: 0971 • ACR Convergence 2022

    Development of a Theory-based Educational Intervention for Fatigue in Systemic Lupus Erythematosus (SLE) Using Human-centered Design Methodology

    Shanthini Kasturi1, Stephanie Tate2, Thomas Farrar3, Lisa Mandl4, Amy LeClair1, Faye Chiu5, Monique Gore-Massy6, Iris Navarro-Millan7 and Sara Folta8, 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA, 3Tufts University School of Medicine, Portland, 4Hospital for Special Surgery, New York, NY, 5N/A, New York, NY, 6Covid-19 GRA, West Orange, NJ, 7Weill Cornell Medicine, New York, NY, 8Tufts University, Boston, MA

    Background/Purpose: Fatigue is a top concern of individuals with SLE and is a leading cause of work impairment and disability in this population. Although fatigue…
  • Abstract Number: 1033 • ACR Convergence 2022

    Risk of Mood Disorders in SpA Patients and Correlations with Disease Activity, Quality of Life and Working Ability: Analysis of a Monocentric Cohort

    Cosimo Cigolini1, Federico Fattorini1, Linda Carli2, Andrea Delle Sedie3, Marta Mosca2 and Gabriele Marchetti4, 1Rheumatology Unit, University of Pisa, Pisa, Toscana, Italy, 2Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, PISA, Italy, 3University of Pisa, Pisa, Pisa, Italy, 4University of Pisa, Pisa, Toscana, Italy

    Background/Purpose: Spondyloarthropathies (SpA) are chronic inflammatory arthritides, characterized by both peripheral and axial skeletal involvement and some typical extra-articular marks; they tend to associate with…
  • Abstract Number: 1220 • ACR Convergence 2022

    Autonomic Dysfunction in Sjogren’s Disease

    Ardy Fenando1, Jordan Estes1, Maha Mohamad1, Sareena Shah2, John Lee2, Duaa Jabari1, Joshua Baker3 and Ghaith Noaiseh1, 1University of Kansas Medical Center, Kansas City, KS, 2University of Missouri-Kansas City, Kansas City, MO, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Sjogren's Disease (SjD) is a heterogenous autoimmune disease associated with debilitating symptoms. Autonomic dysfunction (AD) is common in SjD and may contribute to symptom…
  • Abstract Number: 1270 • ACR Convergence 2022

    MDHAQ/RAPID3 Is a Feasible Tool to Estimate High Comorbid Fatigue and Residual Fatigue in Rheumatoid Arthritis Patients

    Rosa M. Morlà1, Beatriz Frade-Sosa1, Nuria Sapena1, Jose A Gomez-Puerta1, Raimon Sanmarti1 and Theodore Pincus2, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Rush University Medical Center, Chicago, IL

    Background/Purpose: Fatigue is a major symptom for rheumatoid arthritis (RA) patients with a high prevalence (40%-70%)1 measured by different validated questionnaires and scales. A 0-10…
  • Abstract Number: 1344 • ACR Convergence 2022

    Patient-reported Outcomes in Lupus Low Disease Activity State: Impact of Fatigue

    Rodrigo De Moura Rodrigues, Alexandre Moura dos Santos, Daniel Sampaio Cardoso, Emily Figueiredo Neves Yuki, Danieli Castro Oliveira de Andrade, Sandra Gofinet Pasoto, Eduardo Ferreira Borba Neto, Eloisa Silva Dutra de Oliveira Bonfa and Luciana Seguro, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Patient Reported Outcomes (PROs) can be assessed by self-administered questionnaires and can lead to better decision-making by physicians. The aim of this study was…
  • Abstract Number: 1458 • ACR Convergence 2022

    Systemic Lupus Erythematosus (SLE) Patients with Cognitive Impairment Experience More Fatigue Compared to Patients Without Impairment

    Delansie Lawrence1, Jiandong Su1, Andrea Knight2, Kathleen Bingham3, Mahta Kakvan1, Maria Carmela Tartaglia4, Leslet Ruttan5, Joan Wither6, May Choi7, Simone Appenzeller8, Nicole Anderson1, Dennisse Bonilla1, Patricia Katz9, Dorcas Beaton10, Robin Green5, Zahi Touma1 and Michelle Barraclough11, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3Centre for Mental Health, University Health Network; Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 4University of Toronto Krembil Neurosciences Centre, Toronto, ON, Canada, 5University Health Network-Toronto Rehabilitation Institute, Toronto, ON, Canada, 6Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada, 7Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 8Unicamp, Campinas, São Paulo, Brazil, 9UCSF, San Rafael, CA, 10Institute for Work & Health, Toronto, ON, Canada, 11Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, University of Toronto, Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Toronto, ON, Canada

    Background/Purpose: Cognitive impairment (CI) is highly prevalent in patients with systemic lupus erythematosus (SLE). Objective prevalence rates are reported as 38% [range: 20% to 80%]…
  • Abstract Number: 1847 • ACR Convergence 2022

    Differences in Key Patient-reported Outcome Domains Identified by the Patient Acceptable Symptom State in the Adult SAPHO and Chronic Nonbacterial Osteomyelitis Observational Study (The SAPHO-CNO Study)

    Aleksander Lenert1, Robyn Domsic2, Karmela Kim Chan3, Melissa Oliver4, Jisna Paul5, Courtney Kremer6, Emma Leisinger1, Svjetlana Dolovcak7, Sandy D. Hong8, Aruni Jayatilleke9, Petar Lenert7, T. Shawn Sato1, Samir Shah10, Shima Yasin11, Yongdong (Dan) Zhao12, Daniel Solomon13, Jonathan Templin1 and Polly Ferguson11, 1University of Iowa, Iowa City, IA, 2University of Pittsburgh, Pittsburgh, PA, 3Hospital for Special Surgery, New York, NY, 4Indiana University School of Medicine, Indianapolis, IN, 5Ohio State University Hospital, Dublin, OH, 6University of Iowa Stead Family Children's Hospital, Solna, IA, 7University of Iowa Hospitals and Clinics, Iowa City, IA, 8University of Iowa Stead Family Children's Hospital, Iowa City, IA, 9Temple University, PHILADELPHIA, PA, 10Tufts Medical Center, Boston, MA, 11University of Iowa Carver College of Medicine, Iowa City, IA, 12University of Washington, Redmond, WA, 13Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Incorporating patient perspectives of their disease state is needed for disease activity assessment in adults with SAPHO syndrome and chronic nonbacterial osteomyelitis (CNO). The…
  • Abstract Number: 1945 • ACR Convergence 2022

    Determinants of Patient’s Global Assessment of Disease Severity and Predictors of Disease Course in Juvenile Fibromyalgia

    Clara Malattia1, Claudio Lavarello1, Alessandra Alongi2, Benedetta Mori2, Anna Ronchetti3, Lino Nobili4, Lorenzo Chiarella5, Elena Pescio6, Angelo Ravelli7 and Marco Gattorno8, 1Pediatric Clinic and Rheumatology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy,Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal Infantile Sciences (DINOGMI) University of Genoa, Genova, Italy, 2Department of Pediatric Emergency, ARNAS Civico-Di Cristina-Benfratelli, Palermo, Italy, 3Physical Medicine and Rehabilitation Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy, 4Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy,Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal Infantile Sciences (DINOGMI) University of Genoa, Genova, Italy, 5Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy,Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal Infantile Sciences (DINOGMI) University of Genoa, Genova, 6Psychology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy, 7Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal Infantile Sciences (DINOGMI) University of Genoa, Italy,Scientific Direction, IRCCS Istituto Giannina Gaslini, Genova, Italy, 8Pediatric Clinic and Rheumatology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy

    Background/Purpose: Juvenile Fibromyalgia Syndrome (JFS) is a disabling condition characterized by widespread musculoskeletal pain, fatigue and mood disturbances, which impact significantly on patients' quality of…
  • Abstract Number: 2042 • ACR Convergence 2022

    Sjögren’s Disease and Mitochondrial Function

    Biji T Kurien1, Pharaoh Gavin2, Joshua Cavett1, Valerie Lewis3, Ambre Chambers1, Bhaskaran Shylesh4, Anjum Juvaria1, Brittany Karfonta1, Lida Radfar1, Astrid Rasmussen4, Christopher Lessard4, Darise Farris4, Kathy Sivils5, Kristi A Koelsch4, Holly Van Remmen4 and R. Hal Scofield1, 1University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2University of Washington, Seattle, WA, 3Veterans Affairs Medical Center, Oklahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Janssen Research and Development, LLC, Spring House, PA

    Background/Purpose: Sjögren's disease (SjD) is a chronic inflammatory, autoimmune disorder with reduced lacrimal/salivary gland secretion resulting in keratoconjunctivitis sicca and xerostomia, respectively. Also, SjD patients…
  • Abstract Number: 0127 • ACR Convergence 2022

    The Adult SAPHO and Chronic Nonbacterial Osteomyelitis Observational Study (The SAPHO-CNO Study) Supports Multidimensional Disease Symptomatology with High Levels of Pain and Fatigue, and Low Levels of Function

    Aleksander Lenert1, Robyn Domsic2, Karmela Kim Chan3, Melissa Oliver4, Jisna Paul5, Courtney Kremer6, Emma Leisinger1, Svjetlana Dolovcak7, Sandy D. Hong8, Aruni Jayatilleke9, Petar Lenert7, T. Shawn Sato1, Samir Shah10, Shima Yasin11, Yongdong (Dan) Zhao12, Daniel Solomon13, Jonathan Templin1 and Polly Ferguson11, 1University of Iowa, Iowa City, IA, 2University of Pittsburgh, Pittsburgh, PA, 3Hospital for Special Surgery, New York, NY, 4Indiana University School of Medicine, Indianapolis, IN, 5Ohio State University Hospital, Dublin, OH, 6University of Iowa Stead Family Children's Hospital, Solna, IA, 7University of Iowa Hospitals and Clinics, Iowa City, IA, 8University of Iowa Stead Family Children's Hospital, Iowa City, IA, 9Temple University, PHILADELPHIA, PA, 10Tufts Medical Center, Boston, MA, 11University of Iowa Carver College of Medicine, Iowa City, IA, 12University of Washington, Redmond, WA, 13Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Quality of life (QOL) and disease impact are important to adults with SAPHO syndrome and chronic nonbacterial osteomyelitis (CNO) but remain poorly described. Patient-reported…
  • Abstract Number: 2104 • ACR Convergence 2022

    The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE

    Jennifer Rogers1, Amanda Eudy2, Roberta Alexander3, David Pisetsky4, John Conklin3, Kai Sun5, Lisa Criscione-Schreiber6, Jayanth Doss5, Rebecca Sadun5, Mithu Maheswaranathan1 and Megan Clowse5, 1Duke, Durham, NC, 2Duke University, Raleigh, NC, 3Exagen, Inc., Vista, CA, 4Duke University Medical Center, Durham, NC, 5Duke University, Durham, NC, 6Duke University School of Medicine, Durham, NC

    Background/Purpose: Manifestations of SLE can be divided into two subtypes. Type 1 SLE includes classic SLE manifestations that are driven by autoimmune inflammatory mechanisms. Type…
  • Abstract Number: 0204 • ACR Convergence 2022

    Persistence of Fatigue, Sleep Disturbance and Mood Disorders in PMR Patients Despite Standard Treatment

    Jessica Leung1, Claire Owen2, David Liew3 and Russell Buchanan3, 1Austin Health, Preston, Victoria, Australia, 2Austin Health, Malvern East, Australia, 3Austin Health, Heidelberg, Australia

    Background/Purpose: Polymyalgia rheumatica (PMR) is typified by pain and stiffness of the shoulder and hip girdles. Previous qualitative studies have highlighted the importance to patients…
  • Abstract Number: 2111 • ACR Convergence 2022

    Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naïve Patients with Active Psoriatic Arthritis

    Dafna Gladman1, Michael Starr2, Roberto Ranza3, Ana-Maria Bravo Perdomo4, Marcie Strauss5, May Shawi6, Chenglong Han7, Emmanouil Rampakakis8, Andrew Ostor9 and Philip J Mease10, 1Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, ON, Canada, 2Montreal General Hospital, Montréal, QC, Canada, 3Serviço de Reumatología, Universidade Federal de Uberlândia, Uberlândia, Brazil, 4Immunology Medical Affairs, Janssen Latin America, Columbia, Colombia, 5Medasource, Indianapolis, IN, 6Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, PA, 7Immunology, Janssen Research & Development, LLC, Spring House, PA, 8McGill University, Department of Pediatrics and JSS Medical Research, Montréal, QC, Canada, 9Cabrini Medical Centre, Monash University & Emeritus Research, Melbourne, Australia, 10Swedish Medical Center/Providence St. Joseph Health, Seattle, WA

    Background/Purpose: The IL-23p19-subunit inhibitor guselkumab (GUS) demonstrated clinically meaningful improvements in fatigue through one year of treatment1 independent of its effects on ACR20 and MDA…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology